SEARCH RESULTS FOR: "Tag: myov"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2020(1)
2019(4)
CATEGORIES
Analyst Update(1)
Buzz Stocks(3)
Midday Market Check(1)

12/28/2020 10:40 AM
The shares of Myovant Sciences Ltd (NYSE:MYOV) are up 27.2% at $29.08 at last check, gapping to record highs, after the biopharmaceutical concern announced a collaboration with Pfizer (PFE) to develo...
11/19/2019 11:56 AM
Stocks hit new record highs out of the gate as traders cheered news of Boeing's (BA) Dubai Air Show 737 Max jet orders and upbeat housing data. However, the Dow Jones Industrial Average (DJI) and ...
11/19/2019 10:06 AM
At the top of the Nasdaq this morning sits U.K.-based biotech Myovant Sciences Ltd (NYSE:MYOV), up 141% to trade at $14.62. Powering today's breakout is relugolix, the company's treatment for advanced...
8/28/2019 9:35 AM
The shares of U.K.-based biotech Myovant Sciences Ltd (NYSE:MYOV) are popping this morning on a bull note from Goldman Sachs. The analyst initiated coverage on the stock with a "buy" rating, and a $2...
8/19/2019 2:33 PM
The shares of biopharmaceutical concerns Myovant Sciences Ltd (NYSE:MYOV) and NuCana PLC (NASDAQ:NCNA) are higher today, thanks to some optimistic analyst calls. Specifically, SVB Leerink launched ...
PEOPLE ALSO SEARCH FOR
 
Special Offers from Schaeffer's Trading Partners